Home/Filings/4/0001437749-23-017422
4//SEC Filing

Austin Mark John 4

Accession 0001437749-23-017422

CIK 0000728387other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:45 PM ET

Size

5.3 KB

Accession

0001437749-23-017422

Insider Transaction Report

Form 4
Period: 2023-06-12
Austin Mark John
Controller/Prin Fin&Acct Offic
Transactions
  • Award

    Stock Options (right to buy)

    2023-06-12+225,000773,115 total
    Exercise: $0.55Exp: 2033-06-12Common Stock (225,000 underlying)
Footnotes (1)
  • [F1]25% vested as of 6/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 6/12/2024, until fully vested.

Issuer

Perspective Therapeutics, Inc.

CIK 0000728387

Entity typeother

Related Parties

1
  • filerCIK 0001713059

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:45 PM ET
Size
5.3 KB